AgomAb Therapeutics NV AGMB

—

10.51 (0.07) (0.66%) as of 25 Sep

Market cap: $521.1M
P/E: —

Follow AGMB

Overview Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Dec '24	Sep '25	Dec '25	Jun '26
ROIC Full definition →	0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →	0.00%	0.00%	0.00%	0.00%
Free Cash Flow per Share Full definition →	—	—	—	0.00
Free Cash Flow Full definition →	—	—	—	(144.00)
Piotroski F-Score Full definition →	—	—	—	0.00
Other line items
Cash ROIC Full definition →	0.00%	0.00%	0.00%	(23.90%)
Average Days of Payables Full definition →	0.00	0.00	0.00	0.00
Operating CF/Net income Full definition →	—	—	—	0.00
Depreciation/Fixed assets Full definition →	0.00	—	0.00	1.53
Capex/Depreciation Full definition →	—	—	—	0.00
Operating CF per Share Full definition →	—	—	—	0.00

Fold the line items

Columns are period end dates